Vitamin D2 segment is projected to experience the highest growth rate within the Vitamin D market
The vitamin D market size is estimated to be valued at USD 1.3 billion in 2022 and is projected to reach USD 1.9 billion by 2027, recording a CAGR of 7.1% during the forecast period in terms of value.
Increasing consumption of healthy products due to the increasing health and wellness trend has driven the demand for healthy functional ingredients such as vitamin D for use in foods and beverages in these countries.
Furthermore, an increase in expenditure by consumers on healthcare and food & beverage products to compensate for vitamin D deficiencies has also driven the demand for vitamin D in these countries. The increasing prevalence of chronic lifestyle diseases and increasing acceptance of products with additional nutrients and ingredients among consumers are projected to drive market growth during the forecast period.
The Vitamin D2 segment is estimated to grow at the highest growth rate during the forecast period in terms of value.
Vitamin D3 is more effective in raising vitamin D levels in your blood for a longer period than vitamin D2. On the other hand, vitamin D2 is sourced from plants, and vitamin D3 is derived from animals. Vitamin D2 is still prescribed to people with low vitamin D levels, because it's more readily available in higher doses. This change has compelled several manufacturers to shift their production lines from vitamin D3 to vitamin D2. An array of fortified food manufacturers in the global market are expected to experience rising demand for vitamin D2 ingredients as raw material for their line of products.
This report includes a study on the marketing and development strategies, along with the product portfolios of leading companies. It consists of profiles of leading companies, such as Zhejiang Garden Biochemical High-Tech Co.Ltd (China), Koninklijke DSM N.V. (Netherlands), Zhejiang Xinhecheng Co., Ltd. (China), Taizhou Haisheng Pharmaceutical Co., Ltd. (China), Xiamen Jindawei Vitamin Co., Ltd. (China), Fermenta Biotech Ltd. (India), Zhejiang Medicine Co., Ltd.(China), BASF (Germany), and Dishman Group (India).